AdaptHealth Q1 2024 GAAP EPS $(0.02) May Not Be Comparable To $0.05 Estimate, Sales $792.497M Beat $769.867M Estimate
AdaptHealth Q1 2024 GAAP EPS $(0.02) May Not Be Comparable To $0.05 Estimate, Sales $792.497M Beat $769.867M Estimate
AdaptHealth 2024 年第一季度的 GAAP 每股收益 (0.02) 可能无法与预期的0.05美元相提并论，销售额7.92497亿美元超过预期的7.69867亿美元
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 by 140 percent. The company reported quarterly sales of $792.497 million which beat the analyst consensus estimate of $769.867 million by 2.94 percent. This is a 6.43 percent increase over sales of $744.626 million the same period last year.
AdaptHealth（纳斯达克股票代码：AHCO）公布的季度亏损为每股0.02美元，比分析师普遍预期的0.05美元低140％。该公司公布的季度销售额为7.92497亿美元，比分析师普遍预期的7.69867亿美元高出2.94％。这比去年同期的7.44626亿美元的销售额增长了6.43％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。